PE20210780A1 - Compuestos de cianotriazol y usos de los mismos - Google Patents
Compuestos de cianotriazol y usos de los mismosInfo
- Publication number
- PE20210780A1 PE20210780A1 PE2020002084A PE2020002084A PE20210780A1 PE 20210780 A1 PE20210780 A1 PE 20210780A1 PE 2020002084 A PE2020002084 A PE 2020002084A PE 2020002084 A PE2020002084 A PE 2020002084A PE 20210780 A1 PE20210780 A1 PE 20210780A1
- Authority
- PE
- Peru
- Prior art keywords
- isoindolin
- oxoethyl
- carbonitrile
- triazole
- compounds
- Prior art date
Links
- UVQSQWZYJWNHSU-UHFFFAOYSA-N 2h-triazole-4-carbonitrile Chemical class N#CC1=CNN=N1 UVQSQWZYJWNHSU-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000029080 human African trypanosomiasis Diseases 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- OGTPAHFTHDBJBW-UHFFFAOYSA-N 1-[2-[5-[2-(difluoromethyl)pyridin-3-yl]-1,3-dihydroisoindol-2-yl]-2-oxoethyl]-1,2,4-triazole-3-carbonitrile Chemical compound FC(C1=NC=CC=C1C=1C=C2CN(CC2=CC=1)C(CN1N=C(N=C1)C#N)=O)F OGTPAHFTHDBJBW-UHFFFAOYSA-N 0.000 abstract 1
- YRLLBTLYIUKJMO-UHFFFAOYSA-N 1-[2-[5-[3-chloro-5-(trifluoromethyl)pyridin-4-yl]-1,3-dihydroisoindol-2-yl]-2-oxoethyl]-1,2,4-triazole-3-carbonitrile Chemical compound ClC=1C=NC=C(C=1C=1C=C2CN(CC2=CC=1)C(CN1N=C(N=C1)C#N)=O)C(F)(F)F YRLLBTLYIUKJMO-UHFFFAOYSA-N 0.000 abstract 1
- HVEOISVEZISTOU-UHFFFAOYSA-N 1-[2-[5-[4-fluoro-2-(trifluoromethyl)phenyl]-1,3-dihydroisoindol-2-yl]-2-oxoethyl]-1,2,4-triazole-3-carbonitrile Chemical compound FC1=CC(=C(C=C1)C=1C=C2CN(CC2=CC=1)C(CN1N=C(N=C1)C#N)=O)C(F)(F)F HVEOISVEZISTOU-UHFFFAOYSA-N 0.000 abstract 1
- 206010001935 American trypanosomiasis Diseases 0.000 abstract 1
- 208000024699 Chagas disease Diseases 0.000 abstract 1
- 208000004554 Leishmaniasis Diseases 0.000 abstract 1
- 241000223109 Trypanosoma cruzi Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687045P | 2018-06-19 | 2018-06-19 | |
| PCT/IB2019/055123 WO2019244049A1 (fr) | 2018-06-19 | 2019-06-18 | Composés de cyanotriazole et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20210780A1 true PE20210780A1 (es) | 2021-04-21 |
Family
ID=67841115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2020002084A PE20210780A1 (es) | 2018-06-19 | 2019-06-18 | Compuestos de cianotriazol y usos de los mismos |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20220106296A1 (fr) |
| EP (1) | EP3810598A1 (fr) |
| JP (1) | JP2021528397A (fr) |
| KR (1) | KR20210022646A (fr) |
| CN (1) | CN112313217A (fr) |
| AU (1) | AU2019291490B2 (fr) |
| BR (1) | BR112020025538A2 (fr) |
| CA (1) | CA3100954A1 (fr) |
| CL (1) | CL2020003252A1 (fr) |
| CR (1) | CR20200619A (fr) |
| CU (1) | CU20200102A7 (fr) |
| EA (1) | EA202190064A1 (fr) |
| EC (1) | ECSP20080991A (fr) |
| IL (1) | IL279483A (fr) |
| JO (1) | JOP20200327A1 (fr) |
| MA (1) | MA52977A (fr) |
| MX (1) | MX2020013729A (fr) |
| PE (1) | PE20210780A1 (fr) |
| PH (1) | PH12020552186A1 (fr) |
| SG (1) | SG11202012628XA (fr) |
| WO (1) | WO2019244049A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115181060B (zh) * | 2022-08-19 | 2024-03-19 | 江苏禾裕泰化学有限公司 | 一种生产2-氨基-3-氯-5-三氟甲基吡啶的清洁生产工艺 |
| CN116284772B (zh) * | 2023-02-09 | 2024-02-27 | 四川大学 | 一种联吡啶三唑共价有机聚合物及其制备方法和应用 |
| CN116836111A (zh) * | 2023-09-01 | 2023-10-03 | 峰成医药科技(天津)有限公司 | 一种氟代吡啶的连续化合成方法 |
| WO2025163522A1 (fr) * | 2024-01-31 | 2025-08-07 | Novartis Ag | Composés de cyanotriazole et leurs utilisations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2514733A1 (fr) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Compositions pharmaceutiques a base d'un co-cristal |
| US8642774B2 (en) * | 2011-12-08 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Compounds |
| JP6117235B2 (ja) * | 2011-12-15 | 2017-04-19 | ノバルティス アーゲー | Ｐｉ３ｋの活性または機能の阻害剤の使用 |
| AR103219A1 (es) * | 2014-12-22 | 2017-04-26 | Glaxosmithkline Ip Dev Ltd | Compuesto de (1h-indol-3-il)propan-1-ona, composición farmacéutica, combinación y mezcla que lo comprenden y su uso para la fabricación de un medicamento |
-
2019
- 2019-06-18 WO PCT/IB2019/055123 patent/WO2019244049A1/fr not_active Ceased
- 2019-06-18 MX MX2020013729A patent/MX2020013729A/es unknown
- 2019-06-18 JO JOP/2020/0327A patent/JOP20200327A1/ar unknown
- 2019-06-18 CN CN201980040332.3A patent/CN112313217A/zh active Pending
- 2019-06-18 JP JP2020569931A patent/JP2021528397A/ja active Pending
- 2019-06-18 PE PE2020002084A patent/PE20210780A1/es unknown
- 2019-06-18 CU CU2020000102A patent/CU20200102A7/es unknown
- 2019-06-18 SG SG11202012628XA patent/SG11202012628XA/en unknown
- 2019-06-18 MA MA052977A patent/MA52977A/fr unknown
- 2019-06-18 CA CA3100954A patent/CA3100954A1/fr active Pending
- 2019-06-18 BR BR112020025538-6A patent/BR112020025538A2/pt not_active Application Discontinuation
- 2019-06-18 EA EA202190064A patent/EA202190064A1/ru unknown
- 2019-06-18 AU AU2019291490A patent/AU2019291490B2/en not_active Ceased
- 2019-06-18 KR KR1020217001078A patent/KR20210022646A/ko not_active Withdrawn
- 2019-06-18 US US17/253,737 patent/US20220106296A1/en not_active Abandoned
- 2019-06-18 EP EP19762468.7A patent/EP3810598A1/fr not_active Withdrawn
- 2019-06-18 CR CR20200619A patent/CR20200619A/es unknown
-
2020
- 2020-12-15 EC ECSENADI202080991A patent/ECSP20080991A/es unknown
- 2020-12-16 CL CL2020003252A patent/CL2020003252A1/es unknown
- 2020-12-16 PH PH12020552186A patent/PH12020552186A1/en unknown
- 2020-12-16 IL IL279483A patent/IL279483A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP20080991A (es) | 2021-02-26 |
| JP2021528397A (ja) | 2021-10-21 |
| JOP20200327A1 (ar) | 2020-12-15 |
| MX2020013729A (es) | 2021-05-12 |
| US20220106296A1 (en) | 2022-04-07 |
| PH12020552186A1 (en) | 2021-06-07 |
| MA52977A (fr) | 2021-04-28 |
| CU20200102A7 (es) | 2021-08-06 |
| CN112313217A (zh) | 2021-02-02 |
| BR112020025538A2 (pt) | 2021-03-16 |
| AU2019291490B2 (en) | 2022-02-10 |
| CR20200619A (es) | 2021-01-21 |
| CL2020003252A1 (es) | 2021-07-09 |
| AU2019291490A1 (en) | 2021-02-04 |
| SG11202012628XA (en) | 2021-01-28 |
| CA3100954A1 (fr) | 2019-12-26 |
| KR20210022646A (ko) | 2021-03-03 |
| IL279483A (en) | 2021-01-31 |
| WO2019244049A1 (fr) | 2019-12-26 |
| EP3810598A1 (fr) | 2021-04-28 |
| EA202190064A1 (ru) | 2021-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20211810A1 (es) | Compuestos novedosos | |
| EA202092896A1 (ru) | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона | |
| PE20170331A1 (es) | Derivados quinolina como inhibidores smo | |
| PE20191755A1 (es) | Derivados de pirazol como inhibidores de malt 1 | |
| JP2017523997A5 (fr) | ||
| JOP20200194A1 (ar) | صور بلورية جديدة | |
| NO20063748L (no) | Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer | |
| PE20161236A1 (es) | Compuesto de triazina y su uso para fines medicos | |
| PE20181015A1 (es) | 2-amino-3-fluoro-3-(fluorometil)-6-meti-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 | |
| PE20081846A1 (es) | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico | |
| HRP20201355T1 (hr) | Pesticidno aktivni heterociklički derivati sa supstituentima koji sadrže sumpor | |
| EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
| CO6852096A2 (es) | Métodos plaguicidasque utilizan compuestos de 3-piridil tiazol sustituidos y derivados para combatir las plagas de animales i | |
| PE20181074A1 (es) | Compuestos heteroaromaticos como inhibidores de btk | |
| AR037331A1 (es) | Compuestos derivados de 1,2,4-tiadiazol sustituidos, composiciones farmaceuticas que los comprenden, y metodo para preparar dichas composiciones | |
| ES2628005T3 (es) | 2,3-Benzodiazepinas | |
| AR078045A1 (es) | Derivados de pirimidina, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer | |
| PE20180030A1 (es) | Compuestos biciclicos de sulfonamida cetona | |
| PE20151538A1 (es) | Nuevos compuestos como inhibidores de reorganizado durante la transfeccion (ret) | |
| EA201300436A8 (ru) | Совместные кристаллы и соли ингибиторов ccr3 | |
| PE20200342A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue | |
| PE20170946A1 (es) | 2-amino-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 | |
| CO2020012353A2 (es) | Compuestos de pirazol sustituidos con heteroarilo y uso farmacéutico de los mismos | |
| AR100170A1 (es) | Compuestos de diaminotriazina | |
| PE20210044A1 (es) | Compuestos para el tratamiento de trastornos dependientes de cinasas |